🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Jessie Bourcier

Memorial Sloan Kettering Cancer Center

ORCID: 0009-0008-2499-6064

MedicineBiochemistry, Genetics and Molecular BiologyImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “E7820, an anti-cancer sulfonamide, degrades RBM39 in patients with splicing factor mutant myeloid malignancies: a phase II clinical trial”.

E7820, an anti-cancer sulfonamide, degrades RBM39 in patients with splicing factor mutant myeloid malignancies: a phase II clinical trial

Leukemia(2023)10.1038/s41375-023-02050-4

N/A

0.982DataRank · unranked

52 citations

Maximilian Stahl, Justin Taylor, Xiaoli Mi, Namrata S. Chandhok, Justin M. Watts +11 more

Splicing-Mediated Antigen Escape from Immunotherapy for B-cell Malignancies

Blood Cancer Discovery(2021)10.1158/2643-3230.bcd-21-0200

N/A

0DataRank · unranked

6 citations

Omar Abdel-Wahab, Jessie Bourcier

Modulation of RNA splicing enhances response to BCL2 inhibition in leukemia

Cancer Cell(2022)10.1016/j.ccell.2022.12.002

N/A

0DataRank · unranked

78 citations

Jose Mario Bello Pineda, Won Jun Kim, Sisi Chen, Jessie Bourcier, Maximilian Stahl +22 more

Kinase-impaired BTK mutations are susceptible to clinical-stage BTK and IKZF1/3 degrader NX-2127

Science(2024)10.1126/science.adi5798

N/A

0DataRank · unranked

152 citations

Jessie Bourcier, Mark Noviski, Hao Lu, Meghan C. Thompson, Alexandra Chirino +48 more